ConductScience.org, home

Gene · 6286

Papers2,098

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations.Explor Target Antitumor Ther202541216224PubTator, text miningPubMed
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification.Cancer Res Commun202541003647PubTator, text miningPubMed
Integrative single-cell and machine learning approach to characterize immunogenic cell death and tumor microenvironment in LUAD.J Transl Med202540993741PubTator, text miningPubMed
Plasma Circular RNAs in Breast Cancer: From Biomarker Potential to Functional Significance.Cancer Rep (Hoboken)202540965819PubTator, text miningPubMed
Comparing outcomes of systemic anticoagulant therapy and vascular interventional therapy in cerebral venous sinus thrombosis with concurrent brain parenchymal injury: Biomarker analysis.J Med Biochem202540951886PubTator, text miningPubMed
Integrative multi-omics identifies S100A8/IGFBP5/CTSK/S100P as dual diagnostic biomarkers and therapeutic targets in Crohn's disease: from computational discovery to preclinical validation.Int Immunopharmacol202540929958PubTator, text miningPubMed
Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.Nat Commun202540858576PubTator, text miningPubMed
Unveiling the protein landscape for early detection of colorectal precancerous lesions.Clin Proteomics202540841878PubTator, text miningPubMed
Robot-assisted laparoscopic radical prostatectomy for leiomyosarcoma of the prostate: A case report.Int J Surg Case Rep202540840074PubTator, text miningPubMed
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma.NPJ Precis Oncol202540835726PubTator, text miningPubMed
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer.NPJ Precis Oncol202540825842PubTator, text miningPubMed
Fumarate hydratase-deficient renal cell carcinoma with sarcomatoid features: a case report.AME Case Rep202540761212PubTator, text miningPubMed
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation.Sci Adv202540712032PubTator, text miningPubMed
Integrative stemness- and EMT-related gene signatures associated with prognosis and the immune microenvironment in lung adenocarcinoma.Discov Oncol202540531415PubTator, text miningPubMed
A multi-phase approach using supervised algorithms and clinical models to generate high-accuracy signatures for pancreatic cancer.Comput Biol Med202540517592PubTator, text miningPubMed
TRIM29 upregulation contributes to chemoresistance in triple negative breast cancer via modulating S100P-β-catenin axis.Cell Commun Signal202540420099PubTator, text miningPubMed
Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study.World J Emerg Med202540406290PubTator, text miningPubMed
Characterisation of the periodontal proteome in gingival crevicular fluid and saliva using SWATH-MS.Front Cell Infect Microbiol202540384977PubTator, text miningPubMed
Investigating Overlapping Immune-related Genetic Markers in Cholangiocarcinoma and Inflammatory Bowel Disease for Predictive Prognosis.J Immunother202540384613PubTator, text miningPubMed
Soluble form of tumor necrosis factor-related apoptosis-inducing ligand interacts with S100P protein.Int J Biol Macromol202540318722PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6286/papers?page=4